| Enriched cancer pathway | Genes under regulation | P value |
|---|
| Ras signaling pathway |
8 genes: VEGFA, INSR, IGF1R, SYNGAP1, PIK3R1, PLA2G12A, KSR2, PRKCA
|
0.000134 |
| VEGF signaling pathway |
4 genes: PIK3R1, PRKCA, VEGFA, PLA2G12A
|
0.001398 |
| Aldosterone.regulated sodium reabsorption |
3 genes: INSR, PIK3R1, PRKCA
|
0.002396 |
| Notch signaling pathway |
3 genes: DVL3, EP300, NOTCH3
|
0.003307 |
| MAPK signaling pathway |
6 genes: MAPT, PRKCA, PTPRR, CACNA1D, CACNB3, PLA2G12A
|
0.007347 |
| Long.term depression |
3 genes: IGF1R, PRKCA, PLA2G12A
|
0.01005 |
| Adherens junction |
3 genes: EP300, IGF1R, INSR
|
0.01126 |
| Phosphatidylinositol signaling system |
3 genes: PIK3R1, PRKCA, PIP4K2B
|
0.01346 |
| Fc epsilon RI signaling pathway |
3 genes: PIK3R1, PRKCA, PLA2G12A
|
0.01393 |
| GnRH signaling pathway |
3 genes: PRKCA, CACNA1D, PLA2G12A
|
0.02656 |
| Melanogenesis |
3 genes: DVL3, EP300, PRKCA
|
0.02656 |
| Carbohydrate digestion and absorption |
2 genes: PIK3R1, CACNA1D
|
0.03181 |
| Vascular smooth muscle contraction |
3 genes: PRKCA, CACNA1D, PLA2G12A
|
0.03775 |
| Focal adhesion |
4 genes: IGF1R, PIK3R1, PRKCA, VEGFA
|
0.0388 |
| mTOR signaling pathway |
2 genes: PIK3R1, VEGFA
|
0.04316 |